Bernardo Gindri: How platelets Influence Cancer Progression
Bernardo Gindri, Postdoctoral Fellow at NYU Langone Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Advances, adding:
“If you want to learn more about how platelets influence cancer progression and antitumor immunity, check out our latest review,
‘Tumor-platelet cross talk in cancer: mechanisms, thrombotic risk, and translational opportunities,’ published in Blood Advances.
We bring together current mechanistic and translational evidence on how tumors reprogram platelets, how platelets shape the tumor microenvironment and metastatic process, and how these interactions may be leveraged for biomarker development and new therapeutic strategies.
Thank you Tessa Barrett for your support and mentorship, and Zihang Li for helping put this work together!”
Title: Tumor-platelet cross talk in cancer: mechanisms, thrombotic risk, and translational opportunities
Authors: Bernardo Gindri dos Santos, Zihang Li, Tessa J. Barrett
Stay updated with Hemostasis Today.
-
Aug 22, 2026, 11:34Nick Gehrig: Extending Platelet Shelf Life to Strengthen Blood Supply
-
Aug 22, 2026, 11:14Lei Yu: New Guidance for Acute Pulmonary Embolism in 2026
-
Aug 22, 2026, 11:01Neeraj Songara: Shelf-Stable Synthetic Blood – The Future of Emergency Transfusion?
-
Aug 22, 2026, 10:41Mike R.։ VTE Thrombectomy – Defining What Success Really Means
-
Aug 22, 2026, 10:28Steven Meier: What Happens During PRP Therapy?
-
Aug 22, 2026, 10:05Ralf Ludwig: When a Promising Biomarker Falls Short
-
Aug 22, 2026, 09:33Mary Cushman: What Causes PE to Happen in People with DVT?
-
Aug 22, 2026, 07:45Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation
-
Aug 22, 2026, 07:35Archil Jaliashvili: The Real Battle Is Not About Blood Volume — It Is About Oxygen